Your browser doesn't support javascript.
loading
Therapeutic strategy for Fabry disease by intravenous administration of adeno-associated virus 2 or 9 in α-galactosidase A-deficient mice.
Hayashi, Yuka; Sehara, Yoshihide; Watano, Ryota; Ohba, Kenji; Takayanagi, Yuki; Muramatsu, Kazuhiro; Sakiyama, Yoshio; Mizukami, Hiroaki.
Afiliación
  • Hayashi Y; Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
  • Sehara Y; Department of Neurology, Jichi Medical University Saitama Medical Center, Omiya, Japan.
  • Watano R; Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
  • Ohba K; Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
  • Takayanagi Y; Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
  • Muramatsu K; Division of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.
  • Sakiyama Y; Department of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
  • Mizukami H; Department of Neurology, Jichi Medical University Saitama Medical Center, Omiya, Japan.
J Gene Med ; 25(12): e3560, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37392007

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Fabry / Alfa-Galactosidasa Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: J Gene Med Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Fabry / Alfa-Galactosidasa Tipo de estudio: Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: J Gene Med Asunto de la revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Año: 2023 Tipo del documento: Article País de afiliación: Japón
...